These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9990147)

  • 21. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.
    Thomson KS; Sanders CC; Hayden ME
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2329-34. PubMed ID: 1804005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
    Pascual A A; Joyanes P; Martínez-Martínez L; del Carmen Conejo M; Hernández G; Chaves J; Perea EJ
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):432-4. PubMed ID: 11709121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria.
    Odenholt-Tornqvist I; Bengtsson S
    Chemotherapy; 1994; 40(1):30-6. PubMed ID: 8306813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-antibiotic effect of quinolones on Pseudomonas aeruginosa.
    Sood P; Mandal A; Mishra B
    J Antimicrob Chemother; 1999 Mar; 43(3):425-7. PubMed ID: 10223604
    [No Abstract]   [Full Text] [Related]  

  • 25. Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae.
    Mitsuyama J
    J Antimicrob Chemother; 1999 Aug; 44(2):201-7. PubMed ID: 10473226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa.
    Boswell FJ; Andrews JM; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):811-4. PubMed ID: 9222052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
    Pruul H; McDonald PJ
    J Antimicrob Chemother; 1990 Jan; 25(1):91-101. PubMed ID: 2108116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-antibiotic and synergic effects of fluoroquinolones and ceftazidime in combination against Pseudomonas strains.
    Mayer I; Nagy E
    Acta Biol Hung; 2001; 52(2-3):241-8. PubMed ID: 11426858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Rydberg J; Larsson C; Miörner H
    Scand J Infect Dis; 1994; 26(3):317-20. PubMed ID: 7939432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of four fluoroquinolones against clinical isolates of Pseudomonas aeruginosa determined by the E test.
    Swiatlo E; Moore E; Watt J; McDaniel LS
    Int J Antimicrob Agents; 2000 Jun; 15(1):73-6. PubMed ID: 10856680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of furanone on experimentally induced Pseudomonas aeruginosa biofilm formation: in vitro study.
    Kim SG; Yoon YH; Choi JW; Rha KS; Park YH
    Int J Pediatr Otorhinolaryngol; 2012 Nov; 76(11):1575-8. PubMed ID: 22884365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outer membrane changes in quinolone resistant Pseudomonas aeruginosa.
    Hashmi ZS; Smith JM
    J Antimicrob Chemother; 1991 Sep; 28(3):465-70. PubMed ID: 1660047
    [No Abstract]   [Full Text] [Related]  

  • 33. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
    Brazas MD; Hancock RE
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3222-7. PubMed ID: 16048929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.
    Akaniro JC; Stutman HR; Arguedas AG; Vargas OM
    Antimicrob Agents Chemother; 1992 Feb; 36(2):255-61. PubMed ID: 1318674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.
    Kamberi M; Tsutsumi K; Kotegawa T; Kawano K; Nakamura K; Niki Y; Nakano S
    Antimicrob Agents Chemother; 1999 Mar; 43(3):525-9. PubMed ID: 10049262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar.
    Domínguez MC; de La Rosa M; Borobio MV
    J Antimicrob Chemother; 2001 Apr; 47(4):391-8. PubMed ID: 11266409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa.
    Madaras-Kelly KJ; Larsson AJ; Rotschafer JC
    J Antimicrob Chemother; 1996 Apr; 37(4):703-10. PubMed ID: 8722536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin.
    Day CA; Marceau-Day ML; Day DF
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2506-8. PubMed ID: 8285646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.
    Carbone M; Pennisi MG; Masucci M; De Sarro A; Giannone M; Fera MT
    Vet Microbiol; 2001 Jul; 81(1):79-84. PubMed ID: 11356321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antibacterial activity of 4,5,6,7-tetrahydro-thieno[3,2-c]pyridine quinolones.
    Srivastava BK; Solanki M; Mishra B; Soni R; Jayadev S; Valani D; Jain M; Patel PR
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1924-9. PubMed ID: 17276057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.